IL-33 inhibits tumor growth through the activation of anti-tumor CD8+ T cell response in hepatocellular carcinoma

被引：0
|
作者：
Jin, Ziqi [1 ]
Liu, Haiyan [2 ]
机构：
[1] Soochow Univ, Suzhou, Peoples R China
[2] Natl Univ Singapore, Singapore, Singapore
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
57.4
引用
收藏
页数：2
相关论文
共 50 条
  • [1] IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma
    Jin, Ziqi
    Lei, Lei
    Lin, Dandan
    Liu, Yonghao
    Song, Yuan
    Gong, Huanle
    Zhu, Ying
    Mei, Yu
    Hu, Bo
    Wu, Yan
    Zhang, Guangbo
    Liu, Haiyan
    JOURNAL OF IMMUNOLOGY, 2018, 201 (12): : 3770 - 3779
  • [2] Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
    Gao, Xin
    Wang, Xuefeng
    Yang, Qianting
    Zhao, Xin
    Wen, Wen
    Li, Gang
    Lu, Junfeng
    Qin, Wenxin
    Qi, Yuan
    Xie, Fang
    Jiang, Jingting
    Wu, Changping
    Zhang, Xueguang
    Chen, Xinchun
    Turnquist, Heth
    Zhu, Yibei
    Lu, Binfeng
    JOURNAL OF IMMUNOLOGY, 2015, 194 (01): : 438 - 445
  • [3] Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response
    Topchyan, Paytsar
    Xin, Gang
    Chen, Yao
    Zheng, Shikan
    Burns, Robert
    Shen, Jian
    Kasmani, Moujtaba Y.
    Kudek, Matthew
    Yang, Na
    Cui, Weiguo
    CANCERS, 2021, 13 (06) : 1 - 15
  • [4] Sertraline inhibits stress-induced tumor growth through regulating CD8+ T cell-mediated anti-tumor immunity
    Zhou, Shuang
    Ye, Di
    Xia, Hongwei
    Xu, Huanji
    Tang, Weiping
    Tang, Qiulin
    Bi, Feng
    ANTI-CANCER DRUGS, 2022, 33 (09) : 935 - 942
  • [5] Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
    Gao, Kun
    Li, Xiaoying
    Zhang, Li
    Bai, Lin
    Dong, Wei
    Gao, Kai
    Shi, Guiying
    Xia, Xianzhu
    Wu, Lingying
    Zhang, Lianfeng
    CANCER LETTERS, 2013, 335 (02) : 463 - 471
  • [6] A new potential target for enhancing the anti-tumor T cell response: Lysophosphatidic acid signaling inhibits CD8+ T cell activation
    Oda, Shannon
    Fujiwara, Yuko
    Oravecz, Tamas
    Tigyi, Gabor
    Pelanda, Roberta
    Torres, Raul
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [7] Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma
    Chaoul, Nada
    Mancarella, Serena
    Lupo, Luigi
    Giannelli, Gianluigi
    Dituri, Francesco
    CANCERS, 2020, 12 (03)
  • [8] Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells
    Yuan, Chun-Hui
    Sun, Xiao-Ming
    Zhu, Cheng-Liang
    Liu, Shao-Ping
    Wu, Long
    Chen, Hao
    Feng, Mao-Hui
    Wu, Ke
    Wang, Fu-Bing
    ONCOTARGET, 2015, 6 (31) : 32138 - 32153
  • [9] CONTROL OF ANTI-TUMOR CD8+ T-CELL RESPONSES
    Morgan, David J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3413 - 3413
  • [10] Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma
    Zheng, Yanyan
    Lu, Zheng
    Ding, Jiage
    Jiang, Nan
    Wang, Jiawei
    Yang, Jie
    Song, Jingyuan
    Chen, Hongliang
    Fang, Lin
    Li, Huizhong
    Tian, Hui
    Wang, Gang
    Zheng, Junnian
    Chai, Dafei
    CANCERS, 2022, 14 (18)
12345